We are live on ! Find out more
ANVS icon

Annovis Bio
ANVS

23 hedge funds and large institutions have $11.6M invested in Annovis Bio in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

21% more capital invested

Capital invested by funds: $9.6M → $11.6M (+$1.99M)

0.14% more ownership

Funds ownership: 9.08% → 9.22% (+0.14%)

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
+$240K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$223K
3
WANY
Wealthspire Advisors (New York)
New York
+$161K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$131K
5
Koshinski Asset Management
Koshinski Asset Management
Illinois
+$80.7K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$451K
2
BlackRock
BlackRock
New York
-$145K
3
IA
IFP Advisors
Florida
-$44K
4
Osaic Holdings
Osaic Holdings
Arizona
-$19.5K
5
Bank of America
Bank of America
North Carolina
-$14.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$3.74M – – –
BlackRock
2
BlackRock
New York
$1.45M -$145K -8,950 -9%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$796K +$131K +8,092 +19%
MFG
4
Merit Financial Group
Georgia
$661K -$4.04K -250 -0.6%
WFAG
5
Wescott Financial Advisory Group
Pennsylvania
$641K – – –
Bank of New York Mellon
6
Bank of New York Mellon
New York
$527K – – –
RAM
7
Redmond Asset Management
Virginia
$524K – – –
SIAP
8
Sterling Investment Advisors (Pennsylvania)
Pennsylvania
$514K +$14.5K +900 +3%
MWM
9
Modera Wealth Management
New Jersey
$470K – – –
Dimensional Fund Advisors
10
Dimensional Fund Advisors
Texas
$389K +$6.31K +391 +2%
BCM
11
Bridgeway Capital Management
Texas
$364K – – –
State Street
12
State Street
Massachusetts
$296K +$33.9K +2,100 +12%
Koshinski Asset Management
13
Koshinski Asset Management
Illinois
$231K +$80.7K +5,000 +50%
Jane Street
14
Jane Street
New York
$229K +$240K +14,870 New
Susquehanna International Group
15
Susquehanna International Group
Pennsylvania
$213K +$223K +13,800 New
CC
16
Cannell & Co
New York
$154K – – –
WANY
17
Wealthspire Advisors (New York)
New York
$154K +$161K +10,000 New
Wells Fargo
18
Wells Fargo
California
$135K +$16 +1 +0%
TRCT
19
Tower Research Capital (TRC)
New York
$39K +$16.7K +1,036 +68%
Osaic Holdings
20
Osaic Holdings
Arizona
$30.5K -$19.5K -1,210 -36%
Morgan Stanley
21
Morgan Stanley
New York
$26.2K -$451K -27,955 -94%
WWP
22
WR Wealth Planners
Missouri
$2.31K +$2.42K +150 New
IA
23
IFP Advisors
Florida
– -$44K -4,600 Closed
Bank of America
24
Bank of America
North Carolina
– -$14.4K -1,074 Closed
Rockefeller Capital Management
25
Rockefeller Capital Management
New York
– -$13K -1,000 Closed
1
2

ANVS Hedge Fund Activity: Q1 2023 in Review

23 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Annovis Bio (ANVS) for Q1 2023, worth a combined $11.6M — up 21% from $9.6M a quarter earlier.

Fund positioning in ANVS was balanced in Q1 2023: 4 funds opened new positions, 4 closed out, 7 added to existing stakes and 4 trimmed.

The largest buyer was Jane Street, opening a new position worth an estimated $240K. The largest seller was Morgan Stanley, cutting an estimated $451K.

  • 23 institutional investors held Annovis Bio (ANVS) as of Q1 2023, unchanged from Q4 2022.
  • Funds reported $11.6M of Annovis Bio stock for Q1 2023, up 21% quarter-over-quarter.
  • 4 funds opened new Annovis Bio positions in Q1 2023 and 4 closed out, a net change of 0 holders.
  • The largest Annovis Bio buyer in Q1 2023 was Jane Street, an estimated $240K added.
  • The largest Annovis Bio seller in Q1 2023 was Morgan Stanley, an estimated $451K sold.

Based on aggregated 13F filings for Q1 2023.